Amrutanjan Health Care Limited
NSE:AMRUTANJAN.NS
707.2 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 3,795.36 | 3,795.36 | 4,054.469 | 3,315.483 | 2,607.17 | 2,519.686 | 2,220.258 | 2,220.325 | 1,867.435 | 1,665.685 | 1,417.282 | 1,366.563 | 1,431.479 | 1,054.039 | 897.697 | 906.604 | 745.491 | 723.877 |
Cost of Revenue
| 1,819.79 | 1,819.786 | 1,804.625 | 1,401.852 | 1,170.712 | 1,188.932 | 967.735 | 859.959 | 670.355 | 627.538 | 570.049 | 601.528 | 648.15 | 432.554 | 319.413 | 369.546 | 293.284 | 267.722 |
Gross Profit
| 1,975.57 | 1,975.574 | 2,249.844 | 1,913.631 | 1,436.458 | 1,330.754 | 1,252.523 | 1,360.365 | 1,197.08 | 1,038.147 | 847.233 | 765.035 | 783.328 | 621.484 | 578.284 | 537.059 | 452.207 | 456.154 |
Gross Profit Ratio
| 0.521 | 0.521 | 0.555 | 0.577 | 0.551 | 0.528 | 0.564 | 0.613 | 0.641 | 0.623 | 0.598 | 0.56 | 0.547 | 0.59 | 0.644 | 0.592 | 0.607 | 0.63 |
Reseach & Development Expenses
| 11.266 | 11.952 | 11.283 | 8.707 | 10.502 | 10.583 | 9.762 | 9.304 | 4.338 | 1.166 | 1.008 | 1.333 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 489.692 | 44.614 | 27.273 | 24.364 | 24.413 | 24.412 | 31.173 | 13.883 | 7.962 | 265.729 | 33.761 | 35.794 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 524.228 | 525.816 | 729.364 | 555.94 | 515.026 | 493.779 | 437.828 | 376.348 | 299.268 | 202.514 | 199.033 | 167.43 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 1,013.92 | 525.816 | 756.637 | 580.304 | 539.439 | 518.191 | 469.001 | 390.23 | 307.23 | 468.242 | 508.05 | 167.43 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Expenses
| 163.483 | 145.417 | 0.667 | 14.417 | 1.313 | 1.214 | 0.017 | 693.592 | 0.013 | 0.013 | 0.013 | 418.073 | 31.244 | 462.105 | 0.345 | 1.532 | 7.472 | 5.405 |
Operating Expenses
| 1,584.77 | 1,584.766 | 1,450.424 | 1,194.781 | 1,167.519 | 1,035.475 | 985.001 | 1,093.126 | 914.235 | 823.834 | 656.807 | 585.503 | 590.885 | 462.105 | 409.393 | 356.358 | 357.381 | 307.388 |
Operating Income
| 390.81 | 418.549 | 798.407 | 717.93 | 267.757 | 293.514 | 267.522 | 331.35 | 326.833 | 243.191 | 193.804 | 154.742 | 192.444 | 159.379 | 168.891 | 180.7 | 94.826 | 148.766 |
Operating Income Ratio
| 0.103 | 0.11 | 0.197 | 0.217 | 0.103 | 0.116 | 0.12 | 0.149 | 0.175 | 0.146 | 0.137 | 0.113 | 0.134 | 0.151 | 0.188 | 0.199 | 0.127 | 0.206 |
Total Other Income Expenses Net
| 144.65 | 117.905 | 107.359 | 101.115 | 76.782 | 58.159 | 62.034 | 64.11 | 43.988 | 28.877 | 3.379 | -24.79 | -34.538 | -3.374 | 18.449 | -1.968 | -7.809 | -5.986 |
Income Before Tax
| 536.45 | 536.454 | 905.766 | 819.045 | 344.539 | 351.673 | 329.556 | 331.35 | 326.833 | 243.191 | 193.804 | 154.742 | 157.906 | 156.005 | 187.341 | 178.732 | 87.017 | 142.78 |
Income Before Tax Ratio
| 0.141 | 0.141 | 0.223 | 0.247 | 0.132 | 0.14 | 0.148 | 0.149 | 0.175 | 0.146 | 0.137 | 0.113 | 0.11 | 0.148 | 0.209 | 0.197 | 0.117 | 0.197 |
Income Tax Expense
| 138.11 | 138.105 | 233.877 | 207.141 | 93.706 | 101.696 | 129.064 | 117.258 | 121.078 | 92.455 | 69.367 | 53.574 | 61.556 | 53.886 | 72.623 | -745.208 | 36.747 | 83.649 |
Net Income
| 449.726 | 398.349 | 671.889 | 611.904 | 250.833 | 245.143 | 199.73 | 214.092 | 205.755 | 150.736 | 124.438 | 101.168 | 96.35 | 102.119 | 114.717 | 923.94 | 50.27 | 59.131 |
Net Income Ratio
| 0.118 | 0.105 | 0.166 | 0.185 | 0.096 | 0.097 | 0.09 | 0.096 | 0.11 | 0.09 | 0.088 | 0.074 | 0.067 | 0.097 | 0.128 | 1.019 | 0.067 | 0.082 |
EPS
| 13.65 | 13.65 | 23 | 20.94 | 8.58 | 8.39 | 6.83 | 7.46 | 7.67 | 5.1 | 4.26 | 3.46 | 16.23 | 3.37 | 3.78 | 29.05 | 1.57 | 1.85 |
EPS Diluted
| 13.65 | 13.63 | 22.98 | 20.93 | 8.58 | 8.39 | 6.83 | 7.46 | 7.67 | 5.1 | 4.26 | 3.46 | 16.23 | 3.37 | 3.78 | 29.05 | 1.57 | 1.85 |
EBITDA
| 518.113 | 589.34 | 950.013 | 863.514 | 379.719 | 382.219 | 341.829 | 334.917 | 357.952 | 282.088 | 236.785 | 218.314 | 229.563 | 179.078 | 182.399 | 196.192 | 115.751 | 163.979 |
EBITDA Ratio
| 0.137 | 0.155 | 0.234 | 0.26 | 0.146 | 0.152 | 0.154 | 0.151 | 0.192 | 0.169 | 0.167 | 0.16 | 0.16 | 0.17 | 0.203 | 0.216 | 0.155 | 0.227 |